Research Papers:

MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer

Min Li, Kangsheng Gu _, Wei Liu, Xiaoque Xie, Xiaolu Huang and Yiyin Zhang

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:51190-51199. https://doi.org/10.18632/oncotarget.17087

Metrics: PDF 997 views  |   HTML 1908 views  |   ?  


Min Li1, Kangsheng Gu1, Wei Liu2, Xiaoque Xie1 and Xiaolu Huang1

1Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China

2Department of Oncology, Huaibei People’s Hospital, Huaibei, Anhui 235000, P.R. China

Correspondence to:

Kangsheng Gu, email: [email protected]

Keywords: miR-200c, gastric cancer, chemotherapy

Received: December 10, 2016    Accepted: March 21, 2017    Published: April 13, 2017


We examined microRNA-200c (miR-200c) expression in tumor tissues and plasma of patients with advanced gastric cancer and correlated miR-200c expression with treatment efficacy of platinum chemotherapy and patient prognosis. Tumor tissues were collected from 51 patients with advanced gastric cancer who received platinum-containing chemotherapies. The plasma was collected from the same group of patients and 51 subjects with chronic superficial gastritis. Quantitative RT-PCR was used to evaluate miR-200c expression, and its correlation with treatment efficacy and patient prognosis was analyzed.

The results showed that the miR-200c expression in gastric cancer tissues and in plasma were significantly lower than tumor-adjacent tissues and in patients with chronic superficial gastritis (both p <0.05). No significant correlation was found between miR-200c expression in tumors or plasma and clinical characteristics. Patients with higher miR-200c expression had better treatment outcomes with platinum chemotherapy and longer progression-free survival and overall survival than patients with lower miR-200c expression. Receiver-operating characteristic curve analysis showed that miR-200c expression in gastric cancer tissues and plasma distinguished patients’ treatment outcomes. Multivariate analyses confirmed that over expression of miR-200c both in gastric cancer tissue and plasma is associated with longer progression-free survival and overall survival. Taken together, our study indicated that miR-200c expression in gastric cancer tissues and plasma of patients with advanced gastric cancer is associated with better treatment efficacy and prognosis with platinum chemotherapy, suggesting that expression of miR-200c may be predictive for chemotherapy and prognosis in advanced gastric cancer patients.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17087